Upon its recruitment to BME, BM-MSCs differentiates into cancer-associated fibroblasts, resulting in a further increase in MCP-1, GRO-α, IL-6, and IL-8 levels in the tumor microenvironment. The gene discussed is CXCL8; the disease is neoplasm.